HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 44, 43121-43129, October 31, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/44/43121    most recent M306531200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCarthy, T. L. Articles by Centrella, M. Search for Related Content PubMed PubMed Citation Articles by McCarthy, T. L. Articles by Centrella, M. Social Bookmarking                      What's this?

Runx2 Integrates Estrogen Activity in Osteoblasts^*

Thomas L. McCarthy, Wei-Zhong Chang, Yuan Liu, and Michael Centrella

From the Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8041

Steroids significantly effect skeletal integrity. For example, bone mass decreases with glucocorticoid excess or with estrogen depletion after menopause. Glucocorticoid suppresses gene expression by an essential skeletal tissue transcription factor, Runx2, in rat osteoblasts. We now report that estrogen enhances Runx2 activity in dose- and estrogen receptor-dependent ways independently of changes in Runx2 levels or its DNA binding potential. Estrogen receptor and Runx2 can be collected by co-immunoprecipitation. By two-hybrid gene expression analysis, high affinity complex formation involves portions of Runx2 outside of its own DNA binding domain and the DNA binding domain of the estrogen receptor. Consistent with this interaction, the stimulatory effect of estrogen on Runx2 activity is lost when the DNA binding domain of the estrogen receptor is eliminated. Unlike the stimulatory effect of estrogen and the inhibitory effect of glucocorticoid, androgen fails to increase Runx2 activity, whereas Runx2 potently suppresses gene expression induced by all three steroids. Finally, estrogen increases gene transcription by the transforming growth factor- type I receptor gene promoter, which contains several Runx binding sequences, and enhances Smad dependent gene expression by transforming growth factor- in osteoblasts. These results reveal that Runx2 can integrate complex effects on gene transcription in hormone-, growth factor-, and tissue-restricted ways.

Received for publication, June 19, 2003 , and in revised form, August 27, 2003.

^* This work was supported by United States Public Health Service awards AR39201 from NIAMS, National Institutes of Health, and DK56310 from NIDDK, National Institutes of Health, and the Arthritis Foundation Basic Science research program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence may be addressed: 333 Cedar St., P.O. Box 208041, New Haven, CT 06520-8041. Tel.: 203-785-4927; Fax: 203-785-5714; E-mail: thomas.mccarthy{at}yale.edu.

To whom correspondence may be addressed: 333 Cedar St., P.O. Box 208041, New Haven, CT 06520-8041. Tel.: 203-785-4927; Fax: 203-785-5714; E-mail: michael.centrella{at}yale.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. L. McCarthy, M. E. Clough, C. M. Gundberg, and M. Centrella Expression of an estrogen receptor agonist in differentiating osteoblast cultures PNAS, May 13, 2008; 105(19): 7022 - 7027. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella 3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012. [Abstract] [Full Text] [PDF]

				I. Shur, R. Solomon, and D. Benayahu Dynamic Interactions of Chromatin-Related Mesenchymal Modulator, a Chromodomain Helicase-DNA-Binding Protein, with Promoters in Osteoprogenitors. Stem Cells, May 1, 2006; 24(5): 1288 - 1293. [Abstract] [Full Text] [PDF]

				C. K. Inman, N. Li, and P. Shore Oct-1 Counteracts Autoinhibition of Runx2 DNA Binding To Form a Novel Runx2/Oct-1 Complex on the Promoter of the Mammary Gland-Specific Gene {beta}-casein Mol. Cell. Biol., April 15, 2005; 25(8): 3182 - 3193. [Abstract] [Full Text] [PDF]

				X. Luo, L. Ding, J. Xu, and N. Chegini Gene Expression Profiling of Leiomyoma and Myometrial Smooth Muscle Cells in Response to Transforming Growth Factor-{beta} Endocrinology, March 1, 2005; 146(3): 1097 - 1118. [Abstract] [Full Text] [PDF]

				W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF]

				M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130. [Abstract] [Full Text] [PDF]

				C. K. Inman and P. Shore The Osteoblast Transcription Factor Runx2 Is Expressed in Mammary Epithelial Cells and Mediates osteopontin Expression J. Biol. Chem., December 5, 2003; 278(49): 48684 - 48689. [Abstract] [Full Text] [PDF]